Insufficient scRNA-seq data for expression of HSF2BP at single-cell level.
Insufficient scRNA-seq data for expression of HSF2BP at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 95% | 30.34 | 2513 / 2642 | 97% | 5.01 | 687 / 705 |
breast | 97% | 31.30 | 446 / 459 | 88% | 2.48 | 984 / 1118 |
ovary | 100% | 40.72 | 180 / 180 | 85% | 2.79 | 364 / 430 |
uterus | 99% | 31.46 | 169 / 170 | 73% | 2.10 | 336 / 459 |
thymus | 100% | 32.33 | 650 / 653 | 61% | 1.07 | 371 / 605 |
skin | 98% | 41.10 | 1764 / 1809 | 61% | 1.50 | 288 / 472 |
bladder | 100% | 18.76 | 21 / 21 | 55% | 1.38 | 279 / 504 |
lung | 85% | 12.57 | 494 / 578 | 63% | 1.58 | 723 / 1155 |
prostate | 98% | 21.93 | 240 / 245 | 39% | 0.66 | 196 / 502 |
esophagus | 93% | 16.12 | 1350 / 1445 | 40% | 0.82 | 73 / 183 |
intestine | 91% | 15.19 | 882 / 966 | 35% | 0.62 | 186 / 527 |
stomach | 81% | 11.03 | 292 / 359 | 42% | 0.79 | 119 / 286 |
adrenal gland | 89% | 14.13 | 230 / 258 | 27% | 0.40 | 63 / 230 |
kidney | 92% | 17.06 | 82 / 89 | 18% | 0.33 | 164 / 901 |
pancreas | 59% | 5.59 | 193 / 328 | 43% | 0.79 | 77 / 178 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.79 | 1 / 1 |
adipose | 96% | 18.76 | 1157 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 91% | 14.94 | 1217 / 1335 | 0% | 0 | 0 / 0 |
spleen | 83% | 10.10 | 201 / 241 | 0% | 0 | 0 / 0 |
liver | 52% | 5.29 | 118 / 226 | 23% | 0.40 | 93 / 406 |
tonsil | 0% | 0 | 0 / 0 | 73% | 1.84 | 33 / 45 |
eye | 0% | 0 | 0 / 0 | 69% | 1.32 | 55 / 80 |
heart | 62% | 8.81 | 533 / 861 | 0% | 0 | 0 / 0 |
muscle | 49% | 5.32 | 395 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 30% | 5.51 | 281 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.21 | 4 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0007283 | Biological process | spermatogenesis |
GO_1990918 | Biological process | double-strand break repair involved in meiotic recombination |
GO_0007141 | Biological process | male meiosis I |
GO_0007144 | Biological process | female meiosis I |
GO_0005694 | Cellular component | chromosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005515 | Molecular function | protein binding |
Gene name | HSF2BP |
Protein name | Heat shock factor 2-binding protein HSF2BP protein (Heat shock transcription factor 2 binding protein, isoform CRA_b) (cDNA, FLJ94816, Homo sapiens heat shock transcription factor 2 binding protein(HSF2BP), mRNA) Heat shock transcription factor 2 binding protein |
Synonyms | hCG_2007376 MEILB2 |
Description | FUNCTION: Meiotic recombination factor component of recombination bridges involved in meiotic double-strand break repair. Modulates the localization of recombinases DMC1:RAD51 to meiotic double-strand break (DSB) sites through the interaction with BRCA2 and its recruitment during meiotic recombination (By similarity) . Indispensable for the DSB repair, homologous synapsis, and crossover formation that are needed for progression past metaphase I, is essential for spermatogenesis and male fertility (By similarity). Required for proper recombinase recruitment in female meiosis (By similarity). Inhibits BNC1 transcriptional activity during spermatogenesis, probably by sequestering it in the cytoplasm (By similarity). May be involved in modulating HSF2 activation in testis . . |
Accessions | ENST00000443485.1 ENST00000291560.7 [O75031-1] Q6IAT7 O75031 C9JSF2 |